Cargando…
STARD3: A New Biomarker in HER2-Positive Breast Cancer
SIMPLE SUMMARY: One out of 8 breast cancers is of a particular type called “HER2-positive”, which is more aggressive and is treated by surgery and a medical treatment associating chemotherapy and a targeted drug against the protein HER2, possibly followed by radiotherapy and endocrine therapy. When...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9856516/ https://www.ncbi.nlm.nih.gov/pubmed/36672312 http://dx.doi.org/10.3390/cancers15020362 |